Scientific Sessions 2024  /  Too Far Gone? Revascularization of Multivessel CAD in Severe Cardiomyopathy  /  Too Much Too Late: When to Forego Revascularization in Favor of Advanced Heart Failure Therapies
Logo

American Heart Association

  13
  0

Final ID:

Too Much Too Late: When to Forego Revascularization in Favor of Advanced Heart Failure Therapies

  • Pirlamarla, Preethi  ( University of Washington , Seattle , Washington , United States )
  • Lewis, Eldrin  ( STANFORD UNIVERSITY , Palo Alto , California , United States )
  • Uriel, Nir  ( Columbia University , New York , New York , United States )
    • Author Disclosures:
    Preethi Pirlamarla: DO NOT have relevant financial relationships | Eldrin Lewis: DO have relevant financial relationships ; Consultant:Astra Zeneca:Active (exists now) ; Research Funding (PI or named investigator):NIH:Active (exists now) ; Research Funding (PI or named investigator):American Heart Association:Active (exists now) ; Researcher:Idorsia:Active (exists now) ; Consultant:Intellia:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Akebia:Past (completed) | Nir Uriel: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Too Far Gone? Revascularization of Multivessel CAD in Severe Cardiomyopathy

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Complex Case #2 (multivessel CAD in low EF managed with PCI)

Mantha Aditya, Dugan Eunice, Del Cid Fratti Juan, Tiwana Jasleen

Debate: Surgery is the Optimal Modality for Management of Multivessel CAD in Patients with Severe Cardiomyopathy

Lawton Jennifer, Ruel Marc, Zwischenberger Brittany

More abstracts from these authors:
Discussant: SUMMIT

Lewis Eldrin

Navigating Leadership, Mentorship, and Sponsorship: A Personal Path to Professional Growth

Lewis Eldrin

You have to be authorized to contact abstract author. Please, Login
Not Available